Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NOL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OGDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF2H1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMZ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS9D1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FRAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KATNAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLSTN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIBADH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on